These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 16728218)
1. The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the SIRIUS trial). Moussa ID; Moses JW; Kuntz RE; Holmes DR; Popma JJ; Teirstein PS; Wong SC; Leon MB Am J Cardiol; 2006 Jun; 97(11):1582-4. PubMed ID: 16728218 [TBL] [Abstract][Full Text] [Related]
2. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial. Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Alfonso F; Hernández-Antolín R; SanMartín M; Gómez-Hospital JA; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C; Eur Heart J; 2007 Aug; 28(16):1946-52. PubMed ID: 17562666 [TBL] [Abstract][Full Text] [Related]
3. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial. Morice MC; Serruys PW; Barragan P; Bode C; Van Es GA; Stoll HP; Snead D; Mauri L; Cutlip DE; Sousa E J Am Coll Cardiol; 2007 Oct; 50(14):1299-304. PubMed ID: 17903626 [TBL] [Abstract][Full Text] [Related]
4. Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the 'real world'. Jeremias A; Ruisi CP; Kirtane AJ; Lee T; Sylvia B; Pinto DS; Ho KK; Cutlip DE; Carrozza JP; Cohen DJ Coron Artery Dis; 2008 Mar; 19(2):111-5. PubMed ID: 18300748 [TBL] [Abstract][Full Text] [Related]
5. Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study). Maresta A; Varani E; Balducelli M; Varbella F; Lettieri C; Uguccioni L; Sangiorgio P; Zoccai GB; Am J Cardiol; 2008 Jun; 101(11):1560-6. PubMed ID: 18489933 [TBL] [Abstract][Full Text] [Related]
6. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial. Cohen DJ; Bakhai A; Shi C; Githiora L; Lavelle T; Berezin RH; Leon MB; Moses JW; Carrozza JP; Zidar JP; Kuntz RE; Circulation; 2004 Aug; 110(5):508-14. PubMed ID: 15262844 [TBL] [Abstract][Full Text] [Related]
8. Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy). Weisz G; Moses JW; Teirstein PS; Holmes DR; Raizner AE; Satler LF; Mishkel G; Wilensky RL; Wang P; Kuntz RE; Popma JJ; Leon MB Am J Cardiol; 2007 Apr; 99(8):1044-50. PubMed ID: 17437725 [TBL] [Abstract][Full Text] [Related]
9. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries. Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis. Kim YH; Dangas GD; Solinas E; Aoki J; Parise H; Kimura M; Franklin-Bond T; Dasgupta NK; Kirtane AJ; Moussa I; Lansky AJ; Collins M; Stone GW; Leon MB; Moses JW; Mehran R Am J Cardiol; 2008 Mar; 101(6):801-6. PubMed ID: 18328844 [TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial. Moses JW; Nikolsky E; Mehran R; Cambier PA; Bachinsky WB; Leya F; Kuntz RE; Popma JJ; Schleckser P; Wang H; Cohen SA; Leon MB; Am J Cardiol; 2006 Dec; 98(11):1455-60. PubMed ID: 17126649 [TBL] [Abstract][Full Text] [Related]
12. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178 [TBL] [Abstract][Full Text] [Related]
13. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents. Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063 [TBL] [Abstract][Full Text] [Related]
14. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Holmes DR; Leon MB; Moses JW; Popma JJ; Cutlip D; Fitzgerald PJ; Brown C; Fischell T; Wong SC; Midei M; Snead D; Kuntz RE Circulation; 2004 Feb; 109(5):634-40. PubMed ID: 14769686 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of the unrestricted use of sirolimus-eluting stents vs. bare metal stents at 1 and 2-year follow-up: results from the RESEARCH Registry. Ong AT; Daemen J; van Hout BA; Lemos PA; Bosch JL; van Domburg RT; Serruys PW Eur Heart J; 2006 Dec; 27(24):2996-3003. PubMed ID: 17114234 [TBL] [Abstract][Full Text] [Related]
16. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions. Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862 [TBL] [Abstract][Full Text] [Related]
18. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study. Alfonso F; Pérez-Vizcayno MJ; Hernández R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Iñiguez A; Morís C; Cequier A; Sabaté M; Escaned J; Jiménez-Quevedo P; Bañuelos C; Suárez A; Macaya C; J Am Coll Cardiol; 2008 Nov; 52(20):1621-7. PubMed ID: 18992651 [TBL] [Abstract][Full Text] [Related]
19. Sirolimus-eluting stents for the treatment of atherosclerotic ostial lesions. Vijayakumar M; Rodriguez Granillo GA; Lemos PA; Aoki J; Hoye A; Ong AT; McFadden EP; Sianos G; Hofma SH; Smits PC; van der Giessen WJ; de Feyter P; van Domburg RT; Serruys PW J Invasive Cardiol; 2005 Jan; 17(1):10-2. PubMed ID: 15640531 [TBL] [Abstract][Full Text] [Related]
20. Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis. Kim YH; Lee BK; Park DW; Park KH; Choi BR; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ Am J Cardiol; 2006 Dec; 98(11):1451-4. PubMed ID: 17126648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]